LLMpediaThe first transparent, open encyclopedia generated by LLMs

Journal of the American Academy of Dermatology

Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: British Association of Dermatologists Hop 5 terminal

This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.

Journal of the American Academy of Dermatology
TitleJournal of the American Academy of Dermatology
DisciplineDermatology
AbbreviationJ. Am. Acad. Dermatol.
PublisherElsevier
FrequencyMonthly
History1979–present
Issn0190-9622

Journal of the American Academy of Dermatology is a peer-reviewed monthly medical journal covering clinical and investigative dermatology, including clinical trials, consensus guidelines, and reviews. It serves as the flagship publication of a major U.S. professional society and interfaces with international organizations, academic departments, and clinical networks across North America, Europe, and Asia. The journal routinely features contributions from leading academic institutions, hospitals, and regulatory agencies.

History

The journal was established in 1979 amid expansion of specialty journals associated with professional societies such as American Academy of Dermatology, American Medical Association, and Royal College of Physicians. Early editorial leadership drew on faculty from institutions including Johns Hopkins Hospital, Massachusetts General Hospital, and Mayo Clinic, and it expanded alongside developments at Food and Drug Administration and initiatives from World Health Organization on skin disease. Throughout the 1980s and 1990s, the publication paralleled advances reported at conferences like the American Academy of Dermatology meeting, the European Academy of Dermatology and Venereology congress, and the International Society of Dermatology symposia. Shifts in publishing technology involved collaborations with publishers such as Elsevier and transitions that reflected trends seen with titles like New England Journal of Medicine and The Lancet.

Scope and content

The journal's scope includes clinical trials, randomized controlled trials reported at venues such as American College of Physicians meetings, translational research from laboratories affiliated with National Institutes of Health, and clinical practice guidelines influenced by committees from Centers for Disease Control and Prevention and specialty task forces convened by societies including European Academy of Dermatology and Venereology and International League of Dermatological Societies. Content types mirror those in journals like JAMA Dermatology and British Journal of Dermatology: original research, systematic reviews, meta-analyses, case reports, consensus statements, and educational reviews used by residency programs at institutions such as Harvard Medical School, University of California, San Francisco, and Stanford University School of Medicine.

Editorial leadership and peer review

Editorial leadership has included editors drawn from academic centers such as University of Pennsylvania School of Medicine, Yale School of Medicine, and University of Michigan Medical School, and the editorial board often comprises representatives from specialty divisions at Cleveland Clinic, Mount Sinai Health System, and Children's Hospital of Philadelphia. Peer review follows standards adopted by bodies like the International Committee of Medical Journal Editors and plagiarism screening consistent with tools promoted by Committee on Publication Ethics. The peer-review process engages reviewers affiliated with societies including American Academy of Dermatology committees, clinical trial networks registered with ClinicalTrials.gov, and guideline panels funded by agencies such as National Institute for Health and Care Excellence.

Abstracting and indexing

The journal is indexed in major bibliographic services comparable to those listing titles like Annals of Internal Medicine and BMJ. Abstracting and indexing services include databases maintained by PubMed, Scopus, and Web of Science; citation data are tracked alongside metrics compiled by organizations such as Clarivate and analytic platforms used by Google Scholar and Dimensions.

Impact and reception

The journal's impact factor and citation metrics place it among leading specialty publications measured by entities like Clarivate Analytics. Its articles are routinely cited in guidelines from organizations such as American Academy of Family Physicians, referenced in policy documents from Centers for Medicare & Medicaid Services, and discussed at professional meetings including sessions at American Academy of Dermatology meeting and panels organized by Dermatology Nurses' Association. Commentary on practice-changing trials has appeared in broader medical forums such as New England Journal of Medicine editorials and in systematic reviews from consortia including Cochrane Collaboration.

Notable publications and contributions

Notable contributions include randomized trials of biologic therapies presented in parallel with regulatory submissions to Food and Drug Administration and effectiveness studies with long-term data used by payers such as Centers for Medicare & Medicaid Services. The journal has published influential consensus guidelines adopted by international groups like European Academy of Dermatology and Venereology and guideline updates cited by specialty boards such as the American Board of Dermatology. Landmark reviews and clinical series have been authored by investigators from University of Toronto Faculty of Medicine, Imperial College London, and Karolinska Institutet and have informed textbooks used at Columbia University Vagelos College of Physicians and Surgeons.

Access and publication model

The journal operates under a subscription-based model administered by Elsevier with hybrid open-access options similar to those used by titles such as The Lancet Oncology and Cell. Authors may choose open access under Creative Commons licenses to comply with funder mandates from organizations like Wellcome Trust and National Institutes of Health. Publication workflows align with submission systems used across publishers and archiving practices that coordinate with repositories such as PubMed Central and institutional repositories at universities including University of Oxford and University of Cambridge.

Category:Dermatology journals Category:Elsevier academic journals